PrescriberPoint sits at the point of care and rebuilds everything that happens after the pen lifts - coverage, prior auth, samples, savings - so patients actually get their medication.
CAPTION: A clinician clicks once. Behind the click, an AI agent reads the payer's rules, assembles the evidence, and files the form nobody went to medical school to fill out.
A doctor writes a prescription in about thirty seconds. Then the patient waits - sometimes days, sometimes weeks - while the paperwork between prescriber and pharmacy grinds forward. The bottleneck was never the pen. It was everything after it: coverage rules, prior-authorization forms, appeals, copay programs, sample requests, and a scavenger hunt across dozens of manufacturer portals.
PrescriberPoint decided to treat that mess as an engineering problem rather than a fact of life. The Boston company built an AI-enabled point-of-care platform that supports clinicians at every step of the prescribing journey - from researching FDA-approved drug information, to understanding coverage and out-of-pocket costs, to submitting prior authorizations and enrolling patients in the right savings programs. One login. Tens of thousands of medications. Both AI and human support.
Figures reported by the company (2025-2026). Prior-auth acceptance from a study of 1,289 responses in a weight-management practice.
Our AI agent doesn't just fill out forms. It understands what each payer requires, assembles the clinical evidence, and gets patients started on therapy faster.
Retrieves FDA-approved drug and clinical information at the point of care - fast answers without leaving the room.
Automates the full PA lifecycle: script capture in the EMR, payer approval, appeals, and pharmacy routing.
Real-time eligibility and benefit checks that surface payer restrictions in plain language.
Request medication samples directly from manufacturers, minus the detailing ritual.
Finds copay and affordability programs and helps enroll patients who need them.
Ready-to-share materials so patients understand the medication they're starting.
Shared workflow tools so prescribers and staff handle access work together, not in silos.
Study base: 1,289 prior-authorization responses processed through the platform. Bars illustrate the reported split; "163" reflects autonomous answers in the single most complex case.
When Eli Lilly, Pfizer, Adobe, and Mastercard write checks into the same startup, it's worth a second look. PrescriberPoint grew out of work with Eli Lilly and Boston Consulting Group, then raised growth investment from that unlikely coalition with a stated mission to reimagine the traditional HCP-pharmaceutical engagement model.
The business model explains the guest list: PrescriberPoint is free for the clinicians who use it, and pharmaceutical manufacturers pay to reach and support them. Align the incentives around getting patients on therapy, and everyone at the table has a reason to be there.
Origin partner and investor; the company grew out of work with Lilly and BCG.
Strategic investor in the growth financing.
Strategic investor from outside healthcare.
Strategic investor; a payments network in the mix.
Announced agentic AI prior authorization with a 94.5% clinician acceptance rate; presented at the Asembia AXS26 Summit.
Appointed Steven Strongwater, M.D. - a former health-system CEO - as Chief Medical Officer.
Reported reaching more than 5 million healthcare professionals, one of digital health's largest active HCP networks.
Raised growth investment from Lilly, Pfizer, Adobe, and Mastercard to reimagine HCP-pharma engagement.
Founded in Boston, out of work with Eli Lilly and Boston Consulting Group.
PrescriberPoint reports serving 500,000+ U.S. clinicians, with named institutions including Ohio Health, Duke Health, Novant Health, Penn Medicine, and Tufts Medicine. Its stated goal for 2028: help 1 million clinicians with more than 100 million prescriptions. The best products disappear into the workflow, and this one lives where clinicians already are - the point of care.
Sources: prescriberpoint.com, PR Newswire, Morningstar, Fierce Pharma, Crunchbase, PitchBook, CB Insights. Financial and headcount figures are third-party estimates and may be approximate.
The prescription still takes thirty seconds. The difference is what happens next.
Return to the exam room. The doctor lifts the pen, and instead of a three-week wait, a click sets an AI agent loose on the payer's rulebook. Coverage is checked, evidence assembled, the form filed, and - in the best cases - the patient is on therapy inside two days. Same pen. Same thirty seconds. A shorter distance between the decision and the medicine.